Literature DB >> 26645813

Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.

Maria Cristina De Martino1, Peter M van Koetsveld1, Richard A Feelders1, Steven W J Lamberts1, Wouter W de Herder1, Annamaria Colao2, Rosario Pivonello2, Leo J Hofland3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26645813     DOI： 10.1007/s12020-015-0818-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  18 in total

Review 1.  Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?

Authors:  E Baudin; S Leboulleux; A Al Ghuzlan; C Chougnet; J Young; D Deandreis; F Dumont; F Dechamps; C Caramella; P Chanson; E Lanoy; I Borget; M Schlumberger
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.

Authors:  Ilse G Hermsen; Martin Fassnacht; Massimo Terzolo; Saskia Houterman; Jan den Hartigh; Sophie Leboulleux; Fulvia Daffara; Alfredo Berruti; Rita Chadarevian; Martin Schlumberger; Bruno Allolio; Harm R Haak; Eric Baudin
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

3.  Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Berruti; E Baudin; H Gelderblom; H R Haak; F Porpiglia; M Fassnacht; G Pentheroudakis
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

4.  Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.

Authors:  Mabrouka Doghman; Abeer El Wakil; Bruno Cardinaud; Emilie Thomas; Jinling Wang; Wei Zhao; Maria Helena C Peralta-Del Valle; Bonald C Figueiredo; Gerard P Zambetti; Enzo Lalli
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 5.  Human adrenocortical carcinoma cell lines.

Authors:  Tao Wang; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

6.  The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.

Authors:  B Wängberg; A Khorram-Manesh; S Jansson; B Nilsson; O Nilsson; C E Jakobsson; S Lindstedt; A Odén; H Ahlman
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

7.  Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors.

Authors:  Anne O'Donnell; Sandrine Faivre; Howard A Burris; Daniel Rea; Vassiliki Papadimitrakopoulou; Nicholas Shand; Heidi A Lane; Katharine Hazell; Ulrike Zoellner; John M Kovarik; Cathryn Brock; Suzanne Jones; Eric Raymond; Ian Judson
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

8.  Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.

Authors:  Maria Cristina De Martino; Richard A Feelders; Wouter W de Herder; Peter M van Koetsveld; Fadime Dogan; Joseph A M J L Janssen; A Marlijn Waaijers; Claudia Pivonello; Steven W J Lamberts; Annamaria Colao; Ronald R de Krijger; Rosario Pivonello; Leo J Hofland
Journal:  Endocr Relat Cancer       Date:  2014-06-02       Impact factor: 5.678

9.  Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.

Authors:  Peter M van Koetsveld; Giovanni Vitale; Richard A Feelders; Marlijn Waaijers; Diana M Sprij-Mooij; Ronald R de Krijger; Ernst-Jan M Speel; Johannes Hofland; Steven W J Lamberts; Wouter W de Herder; Leo J Hofland
Journal:  Endocr Relat Cancer       Date:  2013-05-30       Impact factor: 5.678

10.  Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.

Authors:  Maria Cristina De Martino; Abir Al Ghuzlan; Sebastien Aubert; Guillaume Assié; Jean-Yves Scoazec; Sophie Leboulleux; Christine Do Cao; Rossella Libè; Cécile Nozières; Marc Lombès; François Pattou; Francoise Borson-Chazot; Ségolène Hescot; Clement Mazoyer; Jacques Young; Isabelle Borget; Annamaria Colao; Rosario Pivonello; Jean-Charles Soria; Jerome Bertherat; Martin Schlumberger; Ludovic Lacroix; Eric Baudin
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958
View more
  6 in total

1.  Palbociclib inhibits proliferation of human adrenocortical tumor cells.

Authors:  Chiara Fiorentini; Martina Fragni; Guido A M Tiberio; Diego Galli; Elisa Roca; Valentina Salvi; Daniela Bosisio; Cristina Missale; Massimo Terzolo; Maurizio Memo; Alfredo Berruti; Sandra Sigala
Journal:  Endocrine       Date:  2017-03-06       Impact factor: 3.633

2.  Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.

Authors:  Antonina Germano; Ida Rapa; Eleonora Duregon; Arianna Votta; Jessica Giorcelli; Consuelo Buttigliero; Giorgio V Scagliotti; Marco Volante; Massimo Terzolo; Mauro Papotti
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

3.  Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.

Authors:  Adwitiya Kar; Yu Zhang; Betelehem W Yacob; Jordan Saeed; Kenneth D Tompkins; Stacey M Bagby; Todd M Pitts; Hilary Somerset; Stephen Leong; Margaret E Wierman; Katja Kiseljak-Vassiliades
Journal:  Endocr Relat Cancer       Date:  2019-10       Impact factor: 5.678

Review 4.  The role of mTOR pathway as target for treatment in adrenocortical cancer.

Authors:  Maria Cristina De Martino; Richard A Feelders; Claudia Pivonello; Chiara Simeoli; Fortuna Papa; Annamaria Colao; Rosario Pivonello; Leo J Hofland
Journal:  Endocr Connect       Date:  2019-09       Impact factor: 3.335

5.  SIRT1 is involved in adrenocortical cancer growth and motility.

Authors:  Adele Chimento; Arianna De Luca; Marta Claudia Nocito; Sara Sculco; Paola Avena; Davide La Padula; Lucia Zavaglia; Rosa Sirianni; Ivan Casaburi; Vincenzo Pezzi
Journal:  J Cell Mol Med       Date:  2021-03-02       Impact factor: 5.310

6.  The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells.

Authors:  B Rubin; C Pilon; R Pezzani; A Rebellato; F Fallo
Journal:  J Endocrinol Invest       Date:  2019-10-05       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.